210 related articles for article (PubMed ID: 28481875)
21. FBXO50 Enhances the Malignant Behavior of Gastric Cancer Cells.
Miwa T; Kanda M; Tanaka H; Tanaka C; Kobayashi D; Umeda S; Iwata N; Hayashi M; Yamada S; Fujii T; Fujiwara M; Kodera Y
Ann Surg Oncol; 2017 Nov; 24(12):3771-3779. PubMed ID: 28560594
[TBL] [Abstract][Full Text] [Related]
22. Extracellular HSP70-peptide complexes promote the proliferation of hepatocellular carcinoma cells via TLR2/4/JNK1/2MAPK pathway.
Zhe Y; Li Y; Liu D; Su DM; Liu JG; Li HY
Tumour Biol; 2016 Oct; 37(10):13951-13959. PubMed ID: 27492456
[TBL] [Abstract][Full Text] [Related]
23. Clinical Utility of a STAT3-Regulated miRNA-200 Family Signature with Prognostic Potential in Early Gastric Cancer.
Yu L; Wu D; Gao H; Balic JJ; Tsykin A; Han TS; Liu YD; Kennedy CL; Li JK; Mao JQ; Tan P; Oshima M; Goodall GJ; Jenkins BJ
Clin Cancer Res; 2018 Mar; 24(6):1459-1472. PubMed ID: 29330205
[No Abstract] [Full Text] [Related]
24. Identification of a molecular signature of prognostic subtypes in diffuse-type gastric cancer.
Kim SK; Kim HJ; Park JL; Heo H; Kim SY; Lee SI; Song KS; Kim WH; Kim YS
Gastric Cancer; 2020 May; 23(3):473-482. PubMed ID: 31773340
[TBL] [Abstract][Full Text] [Related]
25. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864
[TBL] [Abstract][Full Text] [Related]
26. TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53.
Zhou Z; Ji Z; Wang Y; Li J; Cao H; Zhu HH; Gao WQ
Gastroenterology; 2014 Nov; 147(5):1043-54. PubMed ID: 25046164
[TBL] [Abstract][Full Text] [Related]
27. miR-137 plays tumor suppressor roles in gastric cancer cell lines by targeting KLF12 and MYO1C.
Du Y; Chen Y; Wang F; Gu L
Tumour Biol; 2016 Oct; 37(10):13557-13569. PubMed ID: 27468717
[TBL] [Abstract][Full Text] [Related]
28. E2F1-induced upregulation of long noncoding RNA LINC00668 predicts a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically silencing of CKIs.
Zhang E; Yin D; Han L; He X; Si X; Chen W; Xia R; Xu T; Gu D; De W; Guo R; Xu Z; Chen J
Oncotarget; 2016 Apr; 7(17):23212-26. PubMed ID: 27036039
[TBL] [Abstract][Full Text] [Related]
29. MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer.
Yu B; Lv X; Su L; Li J; Yu Y; Gu Q; Yan M; Zhu Z; Liu B
PLoS One; 2016; 11(8):e0158961. PubMed ID: 27518872
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of β-catenin signaling.
Zheng H; Zhang F; Lin X; Huang C; Zhang Y; Li Y; Lin J; Chen W; Lin X
Oncotarget; 2016 Jan; 7(4):4647-63. PubMed ID: 26684358
[TBL] [Abstract][Full Text] [Related]
31. GNA13 as a prognostic factor and mediator of gastric cancer progression.
Zhang JX; Yun M; Xu Y; Chen JW; Weng HW; Zheng ZS; Chen C; Xie D; Ye S
Oncotarget; 2016 Jan; 7(4):4414-27. PubMed ID: 26735177
[TBL] [Abstract][Full Text] [Related]
32. Tissue transglutaminase-2 promotes gastric cancer progression via the ERK1/2 pathway.
Wang X; Yu Z; Zhou Q; Wu X; Chen X; Li J; Zhu Z; Liu B; Su L
Oncotarget; 2016 Feb; 7(6):7066-79. PubMed ID: 26771235
[TBL] [Abstract][Full Text] [Related]
33. Folate receptor α increases chemotherapy resistance through stabilizing MDM2 in cooperation with PHB2 that is overcome by MORAb-202 in gastric cancer.
Sakai H; Kawakami H; Teramura T; Onodera Y; Somers E; Furuuchi K; Uenaka T; Kato R; Nakagawa K
Clin Transl Med; 2021 Jun; 11(6):e454. PubMed ID: 34185411
[TBL] [Abstract][Full Text] [Related]
34. miR-488 acts as a tumor suppressor gene in gastric cancer.
Zhao Y; Lu G; Ke X; Lu X; Wang X; Li H; Ren M; He S
Tumour Biol; 2016 Jul; 37(7):8691-8. PubMed ID: 26738864
[TBL] [Abstract][Full Text] [Related]
35. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
[No Abstract] [Full Text] [Related]
36. miR-493 mediated DKK1 down-regulation confers proliferation, invasion and chemo-resistance in gastric cancer cells.
Jia X; Li N; Peng C; Deng Y; Wang J; Deng M; Lu M; Yin J; Zheng G; Liu H; He Z
Oncotarget; 2016 Feb; 7(6):7044-54. PubMed ID: 26799283
[TBL] [Abstract][Full Text] [Related]
37. Rab40b upregulation correlates with the prognosis of gastric cancer by promoting migration, invasion, and metastasis.
Li Y; Jia Q; Wang Y; Li F; Jia Z; Wan Y
Med Oncol; 2015 Apr; 32(4):126. PubMed ID: 25790780
[TBL] [Abstract][Full Text] [Related]
38. Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients.
Altan B; Yokobori T; Ide M; Mochiki E; Toyomasu Y; Kogure N; Kimura A; Hara K; Bai T; Bao P; Suzuki M; Ogata K; Asao T; Nishiyama M; Oyama T; Kuwano H
Gastric Cancer; 2016 Jul; 19(3):789-97. PubMed ID: 26472729
[TBL] [Abstract][Full Text] [Related]
39. STAT3-driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammation.
Tye H; Kennedy CL; Najdovska M; McLeod L; McCormack W; Hughes N; Dev A; Sievert W; Ooi CH; Ishikawa TO; Oshima H; Bhathal PS; Parker AE; Oshima M; Tan P; Jenkins BJ
Cancer Cell; 2012 Oct; 22(4):466-78. PubMed ID: 23079657
[TBL] [Abstract][Full Text] [Related]
40. Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1.
Yuan C; Zhu X; Han Y; Song C; Liu C; Lu S; Zhang M; Yu F; Peng Z; Zhou C
J Exp Clin Cancer Res; 2016 Jan; 35():15. PubMed ID: 26791264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
